LIT references

LIT references

1.      Mowbray JF, Gibbings C, Liddell H, Reginald PW, Underwood JL, Beard RW: Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet 1985; 1(8435):941-3

2.      Recurrent Miscarriage Immunotherapy Trialists Group: Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 1994;32(2):55-72

3.      Gharesi-Fard B, Zolghadri J, Foroughinia L, Tavazoo F, Samsami Dehaghani A: Effectiveness of leukocyte immunotherapy in primary recurrent spontaneous abortion (RSA). Iran J Immunol. 2007;4(3):173-8

4.      Kano T, Mori T, Furudono M, Ishikawa H, Watanabe H, Kikkawa E, Warita T, Onizuka M, Takahashi M, Maeda Y, Naruse T, Inoko H, Kimura A: Human leukocyte antigen may predict outcome of primary recurrent spontaneous abortion treated with paternal lymphocyte alloimmunization therapy. Am J Reprod Immunol 2007;58(4):383-7.

5.      Gilman-Sachs A, Luo SP, Beer AE, Beaman KD: Analysis of anti-lymphocyte antibodies by flow cytometry or microlymphocytotoxicity in women with recurrent spontaneous abortions immunized with paternal leukocytes. J Clin Lab Immunol. 1989;30(2):53-9.

6.      Pandey MK, Thakur S, Agrawal: Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Arch Gynecol Obstet 2004; 269(3) 161-72.

7.      Gorczynski RM: Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection. Transplantation 2006;81(7):1027-34

8.      Zaba LC, Fuentes-Duculan J, Steinman RM, Krueger JG, Lowes MA: Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J Clin Invest. 2007; 117(9):2517-25

9.      Gafter U, Sredni B, Segal J, Kalechman Y: Suppressed Cell-Mediated Immunity and Monocyte and Natural Killer Cell Activity Following Allogeneic Immunization of Women with Spontaneous Recurrent Abortion. J Clin Immunol. 1997;17(5):408-19

10. Pandey MK, Agrawal S: Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion. Int Immunopharmacol 2004;4(2):289-98.

11. Kling C, Steinnmann J, Westpahl E, Magez J, Kabelitz D: Adverse effects of intradermal allogeneic lymphocyte immunotherapy: acute reactions and role of autoimmunity. Human Reproduction 2006; 21(2)429-35

12. Kling C, Steinnmann J, Flesch B, Westpahl E, Kabelitz D: Transfusion-related risks of intradermal allogeneic lymphocyte immunotherapy: single cases in a large cohort and review of the literature. Am J Reprod Immunol 2006; 56(3)157-71

13. E. Winger, J. Reed, R. Stricker. Lymphocyte Immunization Therapy (LIT) Combined with Intravenous Immunoglobulin (IVIG) Improves Live Birth Rates in Women with Primary Recurrent Spontaneous Abortion (RSA) European Conference for Reproductive Immunology, Berlin, Germany, Sept 2 2007.

14. Ober C, Karrison T, Odem RR, Barnes RB, Branch DW, Stephenson MD, Baron B, Walker MA, Scott JR, Schreiber JR: Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet 1999 354(9176):365-9.

15. Clark DA, Chaouat G: Loss of surface CD200 on stored allogeneic leukocytes may impair anti-abortive effect in vivo. Am J Reprod Immunol 2005;53:13-20

16. FDA letter on LIT: https://wayback.archive-it.org/7993/20170406072912/https://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm105848.htm

 

.